Clinical Trial Update: Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

Clinical trial update for pegyliposomal doxorubicin and 5-fluorouracil as second-line therapy in metastatic gastric cancer (Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• pegyliposomal doxorubicin (pegyliposomal doxorubicin)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN